The Cochrane Library: Cochrane Database of Systematic Reviews

DOI: 10.1002/14651858

Reviews/Protocols listed by Cochrane Review Group

  1. Cochrane Acute Respiratory Infections Group
  2. Cochrane Airways Group
  3. Cochrane Anaesthesia, Critical and Emergency Care Group
  4. Cochrane Back and Neck Group
  5. Cochrane Bone, Joint and Muscle Trauma Group
  6. Cochrane Breast Cancer Group
  7. Cochrane Childhood Cancer Group
  8. Cochrane Colorectal Cancer Group
  9. Cochrane Common Mental Disorders Group
  10. Cochrane Consumers and Communication Group
  11. Cochrane Cystic Fibrosis and Genetic Disorders Group
  12. Cochrane Dementia and Cognitive Improvement Group
  13. Cochrane Developmental, Psychosocial and Learning Problems Group
  14. Cochrane Drugs and Alcohol Group
  15. Cochrane Effective Practice and Organisation of Care Group
  16. Cochrane ENT Group
  17. Cochrane Epilepsy Group
  18. Cochrane Eyes and Vision Group
  19. Cochrane Fertility Regulation Group
  20. Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group
    1. About this group
    2. Reviews
      1. Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancerReview
      2. Adjuvant chemotherapy for advanced endometrial cancerReview
      3. Adjuvant chemotherapy for endometrial cancer after hysterectomyReview
      4. Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adultsReview
      5. Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal womenReview
      6. Adjuvant platinum-based chemotherapy for early stage cervical cancerReview
      7. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancerReview
      8. Adjuvant progestagens for endometrial cancerReview
      9. Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcomaReview
      10. Adjuvant radiotherapy for stage I endometrial cancerReview
      11. Adjuvant treatment of anaplastic oligodendrogliomas and oligoastrocytomasReview
      12. Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropeniaReview
      13. Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patientsReview
      14. Angiogenesis inhibitors for the treatment of ovarian cancerReview
      15. Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactamsReview
      16. Antiangiogenic therapy for high-grade gliomaReview
      17. Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapyReview
      18. Anticoagulation for people with cancer and central venous cathetersReview
      19. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancerReview
      20. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancerReview
      21. Antidepressants for the treatment of depression in people with cancerReview
      22. Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infectionsReview
      23. Antigen-specific active immunotherapy for ovarian cancerReview
      24. Autologous hematopoietic stem cell transplantation following high dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomasReview
      25. Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropeniaReview
      26. Biopsy versus resection for high grade gliomaReview
      27. Biopsy versus resection for the management of low-grade gliomasReview
      28. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapyReview
      29. Cardioprotective interventions for cancer patients receiving anthracyclinesReview
      30. Centralisation of services for gynaecological cancerReview
      31. Chemoradiation for advanced primary vulval cancerReview
      32. Chemotherapy and/or radiotherapy in combination with surgery for ovarian carcinosarcoma Review
      33. Chemotherapy for advanced ovarian cancerReview
      34. Chemotherapy for advanced, recurrent or metastatic endometrial carcinomaReview
      35. Chemotherapy for high-grade gliomaReview
      36. Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent diseaseReview
      37. Chemotherapy for metastatic and recurrent cervical cancerReview
      38. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasiaReviewNew Search
      39. Chemotherapy for thymic carcinoma and advanced thymoma in adultsReview
      40. Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancerReview
      41. Chemotherapy wafers for high grade gliomaReview
      42. Collection devices for obtaining cervical cytology samplesReview
      43. Colony-stimulating factors for chemotherapy-induced febrile neutropeniaReview
      44. Combination chemotherapy for primary treatment of high-risk gestational trophoblastic tumourReview
      45. Combined use of hyperthermia and radiation therapy for treating locally advanced cervix carcinomaReview
      46. Communication skills training for healthcare professionals working with people who have cancerReview
      47. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervixReview
      48. Concomitant hydroxyurea plus radiotherapy versus radiotherapy for carcinoma of the uterine cervixReview
      49. Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancerReview
      50. Dance/movement therapy for improving psychological and physical outcomes in cancer patientsReview
      51. Different anthracycline derivates for reducing cardiotoxicity in cancer patientsReview
      52. Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapyReview
      53. Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcomaReview
      54. Early versus delayed postoperative radiotherapy for treatment of low-grade gliomasReview
      55. Effectiveness of different treatment modalities for the management of adult-onset granulosa cell tumours of the ovary (primary and recurrent)Review
      56. Effectiveness of tranexamic acid in reducing blood loss during cytoreductive surgery for advanced ovarian cancerReviewNew
      57. Electric fans for reducing adverse health impacts in heatwavesReview
      58. Empirical antibiotics targeting Gram-positive bacteria for the treatment of febrile neutropenic patients with cancerReview
      59. Epidermal growth factor receptor blockers for the treatment of ovarian cancerReview
      60. Evaluation of follow-up strategies for patients with epithelial ovarian cancer following completion of primary treatmentReview
      61. Exenterative surgery for recurrent gynaecological malignanciesReview
      62. Exercise interventions on health-related quality of life for cancer survivorsReview
      63. Exercise interventions on health-related quality of life for people with cancer during active treatmentReview
      64. Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasiaReview
      65. First-line chemotherapy in low-risk gestational trophoblastic neoplasiaReview
      66. Follow-up protocols for women with cervical cancer after primary treatmentReview
      67. Follow-up strategies after treatment (large loop excision of the transformation zone (LLETZ)) for cervical intraepithelial neoplasia (CIN): Impact of human papillomavirus (HPV) testReview
      68. Ganoderma lucidum (Reishi mushroom) for cancer treatmentReview
      69. Granulocyte transfusions for preventing infections in people with neutropenia or neutrophil dysfunctionReview
      70. Granulocyte transfusions for treating infections in patients with neutropenia or neutrophil dysfunctionReview
      71. Green tea (Camellia sinensis) for the prevention of cancerReview
      72. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancerReview
      73. Hormonal therapy in advanced or recurrent endometrial cancerReview
      74. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesionsReviewDiagnostic
      75. Hyperbaric oxygen therapy for late radiation tissue injuryReview
      76. Hyperbaric oxygenation for tumour sensitisation to radiotherapyReview
      77. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancerReview
      78. Image guided surgery for the resection of brain tumoursReview
      79. Influenza vaccines in immunosuppressed adults with cancerReview
      80. Interferon after surgery for women with advanced (Stage II-IV) epithelial ovarian cancerReview
      81. Interval debulking surgery for advanced epithelial ovarian cancerReview
      82. Interventions for encouraging sexual behaviours intended to prevent cervical cancerReview
      83. Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiationReview
      84. Interventions for preventing blood loss during the treatment of cervical intraepithelial neoplasiaReview
      85. Interventions for promoting habitual exercise in people living with and beyond cancerReview
      86. Interventions for psychosexual dysfunction in women treated for gynaecological malignancyReview
      87. Interventions for reducing anxiety in women undergoing colposcopyReview
      88. Interventions for the physical aspects of sexual dysfunction in women following pelvic radiotherapyReview
      89. Interventions for the treatment of borderline ovarian tumoursReview
      90. Interventions for the treatment of Paget's disease of the vulvaReview
      91. Interventions targeted at women to encourage the uptake of cervical screeningReview
      92. Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancerReview
      93. Laetrile treatment for cancerReview
      94. Laparoscopically assisted radical vaginal hysterectomy versus radical abdominal hysterectomy for the treatment of early cervical cancerReview
      95. Laparoscopy for diagnosing resectability of disease in patients with advanced ovarian cancerReviewDiagnostic
      96. Laparoscopy versus laparotomy for FIGO stage I ovarian cancerReview
      97. Laparoscopy versus laparotomy for the management of early stage endometrial cancerReview
      98. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancerReview
      99. Lymphadenectomy for the management of endometrial cancerReview
      100. Maintenance chemotherapy for ovarian cancerReview
      101. Management of drainage for malignant ascites in gynaecological cancerReview
      102. Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasiaReviewNew
      103. Medical interventions for high-grade vulval intraepithelial neoplasiaReview
      104. Mistletoe therapy in oncologyReview
      105. Multidimensional rehabilitation programmes for adult cancer survivorsReview
      106. Music interventions for improving psychological and physical outcomes in cancer patientsReview
      107. Neoadjuvant chemotherapy for locally advanced cervix cancerReview
      108. Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancerReview
      109. Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasiaReview
      110. Non-surgical interventions for late radiation cystitis in patients who have received radical radiotherapy to the pelvisReview
      111. Non surgical interventions for late radiation proctitis in patients who have received radical radiotherapy to the pelvisReview
      112. Nutritional interventions for reducing gastrointestinal toxicity in adults undergoing radical pelvic radiotherapyReview
      113. Nystatin prophylaxis and treatment in severely immunodepressed patientsReview
      114. Optimal primary surgical treatment for advanced epithelial ovarian cancerReview
      115. Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulationReview
      116. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patientsReview
      117. Pain relief for women with cervical intraepithelial neoplasia undergoing colposcopy treatmentReview
      118. Palliative interventions for controlling vaginal bleeding in advanced cervical cancerReview
      119. Palliative surgery versus medical management for bowel obstruction in ovarian cancerReview
      120. Parenteral anticoagulation in ambulatory patients with cancerReview
      121. Patient-reported outcome measures for follow-up after gynaecological cancer treatmentReview
      122. Pegylated liposomal doxorubicin for first-line treatment of epithelial ovarian cancerReview
      123. Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancerReview
      124. Perioperative enhanced recovery programmes for gynaecological cancer patientsReview
      125. Perioperative nutrition interventions for women with ovarian cancerReview
      126. Pharmacological treatment of depression in patients with a primary brain tumourReview
      127. Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancerReview
      128. Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised peopleReviewDiagnostic
      129. Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancerReview
      130. Primary groin irradiation versus primary groin surgery for early vulvar cancerReview
      131. Primary surgery versus primary radiotherapy with or without chemotherapy for early adenocarcinoma of the uterine cervixReview
      132. Prophylactic antibiotics for preventing Gram positive infections associated with long-term central venous catheters in oncology patientsReview
      133. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasiaReview
      134. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patientsReview
      135. Psychosocial interventions to improve quality of life and emotional wellbeing for recently diagnosed cancer patientsReview
      136. Radiotherapy and chemoradiation after surgery for early cervical cancerReview
      137. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysisReview
      138. Retinoids for preventing the progression of cervical intra-epithelial neoplasiaReview
      139. Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy for the prevention of lymphocyst formation in patients with gynaecological malignanciesReview
      140. Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertilityReview
      141. Robot-assisted surgery in gynaecologyReview
      142. Robotic assisted surgery for gynaecological cancerReviewWithdrawn
      143. Robotic surgery for benign gynaecological diseaseReviewWithdrawn
      144. Routine versus selective antifungal administration for control of fungal infections in patients with cancerReview
      145. Selenium for preventing cancerReview
      146. Sentinel node assessment for diagnosis of groin lymph node involvement in vulval cancerReviewDiagnostic
      147. Short versus long duration infusions of paclitaxel for any advanced adenocarcinomaReview
      148. Surgery for cervical intraepithelial neoplasiaReview
      149. Surgery or radiosurgery plus whole brain radiotherapy versus surgery or radiosurgery alone for brain metastasesReview
      150. Surgical cytoreduction for recurrent epithelial ovarian cancerReview
      151. Surgical interventions for early squamous cell carcinoma of the vulvaReview
      152. Surgical interventions for high-grade vulval intraepithelial neoplasiaReview
      153. Surgical resection and whole brain radiation therapy versus whole brain radiation therapy alone for single brain metastasesReview
      154. Surgical treatment of stage IA2 cervical cancerReview
      155. Tamoxifen for relapse of ovarian cancerReview
      156. Temozolomide for high grade gliomaReview
      157. Thalidomide for managing cancer cachexiaReview
      158. Thymic peptides for treatment of cancer patientsReview
      159. Topotecan for ovarian cancerReview
      160. Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancerReview
      161. Vaginal dilator therapy for women receiving pelvic radiotherapyReview
      162. Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropeniaReview
      163. Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastasesReview
      164. Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastasesReview
    3. Protocols
      1. (1[RIGHTWARDS ARROW]3)β-D-glucan testing for the detection of invasive fungal infections in immunocompromised patientsProtocolDiagnostic
      2. Adjuvant radiotherapy after surgery for vulval cancerProtocol
      3. Adjuvant treatment after hysterectomy for uterine leiomyosarcomaProtocol
      4. Antibiotics for infection prevention after excision of the cervical transformation zoneProtocol
      5. Awake language mapping for cerebral glioma surgeryProtocol
      6. Cytology versus HPV testing for cervical cancer screening in the general populationProtocolDiagnostic
      7. Dietary interventions for adult cancer survivorsProtocol
      8. External beam radiation dose escalation for high grade gliomaProtocol
      9. Gemcitabine for platinum-resistant or recurrent ovarian cancerProtocol
      10. Ginseng for improving the quality of life in people with cancerProtocol
      11. Hormone replacement therapy for women previously treated for endometrial cancerProtocol
      12. Impact of epithelial ovarian cancer screening on patient-relevant outcomes in average-risk postmenopausal womenProtocol
      13. Interventions for the management of fatigue in adults with a primary brain tumourProtocol
      14. Interventions for the treatment of brain radionecrosis after radiotherapy or radiosurgeryProtocol
      15. Intra-arterial chemotherapy for high-grade gliomasProtocol
      16. Intra-operative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic massesProtocolDiagnostic
      17. Intralesional treatment versus wide resection for central chondrosarcoma grade I in the long bonesProtocol
      18. Low cost versus other screening tests to detect cervical cancer or precancer in developing countriesProtocolDiagnostic
      19. Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancerProtocol
      20. Lymph node dissection (lymphadenectomy) for presumed early stage epithelial ovarian cancerProtocol
      21. Magnetic resonance perfusion for differentiating low grade from high grade gliomas at first presentationProtocolDiagnostic
      22. Maintenance bioimmunotherapy for epithelial ovarian cancerProtocol
      23. Management of low-grade squamous intra-epithelial lesions of the uterine cervix: repeat cytology versus immediate referral to colposcopyProtocol
      24. Melatonin in cancer treatmentProtocol
      25. Moxibustion for alleviating side effects of chemotherapy or radiotherapy in cancer patientsProtocol
      26. Non-pharmacological interventions for cognitive impairment due to systemic cancer treatmentProtocol
      27. Non-pharmacological interventions for the treatment of sleep-wake disturbances in patients with cancerProtocol
      28. Outpatient treatment for patients with cancer who develop a low-risk febrile neutropenic eventProtocol
      29. Pharmacological interventions for the prevention of insufficiency fractures and avascular necrosis associated with pelvic radiotherapy in adultsProtocol
      30. Probiotics for the prevention or treatment of chemotherapy or radiotherapy related diarrhoea in cancer patientsProtocol
      31. Procarbazine, lomustine and vincristine for recurrent high-grade gliomaProtocol
      32. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursorsProtocol
      33. Psychological interventions for cancer survivors and cancer patients in the palliative phaseProtocol
      34. Risk of endometrial cancer in women treated with ovary-stimulating drugs for subfertilityProtocol
      35. Sentinel node biopsy for diagnosis of pelvic lymph node involvement in early stage cervical cancerProtocolDiagnostic
      36. Surgery plus adjuvant radiotherapy versus surgery alone for stage II endometrial cancerProtocol
      37. Symptoms, ultrasound imaging and biochemical markers alone or in combination for the diagnosis of ovarian cancer in women with symptoms suspicious of ovarian cancerProtocolDiagnostic
      38. Taxane monotherapy for the treatment of platinum pre-treated epithelial ovarian cancerProtocol
      39. Taxane platinum combination chemotherapy versus single agent platinum for the first line treatment of epithelial ovarian cancerProtocolWithdrawn
      40. Telephone interventions for symptom management in adults with cancerProtocol
      41. Type II or type III radical hysterectomy compared to chemoradiotherapy as a primary treatment for stage IB2 cervical cancerProtocol
      42. Weekly versus tri-weekly paclitaxel with carboplatin for first-line treatment in women with ovarian cancerProtocol
  21. Cochrane Gynaecology and Fertility Group
  22. Cochrane Haematological Malignancies Group
  23. Cochrane Heart Group
  24. Cochrane Hepato-Biliary Group
  25. Cochrane HIV/AIDS Group
  26. Cochrane Hypertension Group
  27. Cochrane IBD Group
  28. Cochrane Incontinence Group
  29. Cochrane Infectious Diseases Group
  30. Cochrane Injuries Group
  31. Cochrane Kidney and Transplant Group
  32. Cochrane Lung Cancer Group
  33. Cochrane Metabolic and Endocrine Disorders Group
  34. Cochrane Methodology Review Group
  35. Cochrane Movement Disorders Group
  36. Cochrane Multiple Sclerosis and Rare Diseases of the CNS Group
  37. Cochrane Musculoskeletal Group
  38. Cochrane Neonatal Group
  39. Cochrane Neuromuscular Group
  40. Cochrane Oral Health Group
  41. Cochrane Pain, Palliative and Supportive Care Group
  42. Cochrane Pregnancy and Childbirth Group
  43. Cochrane Public Health Group
  44. Cochrane Schizophrenia Group
  45. Cochrane Skin Group
  46. Cochrane STI Group
  47. Cochrane Stroke Group
  48. Cochrane Tobacco Addiction Group
  49. Cochrane Upper GI and Pancreatic Diseases Group
  50. Cochrane Urology Group
  51. Cochrane Vascular Group
  52. Cochrane Work Group
  53. Cochrane Wounds Group